What is leukemia?
- Any cancer is caused by an uncontrolled or unregulated growth of abnormal cells. Leukemia involves the uncontrolled growth of the bone marrow cells
- Leukemia cells, unlike other types of cancers, generally do not clump to form a mass (tumor). Due to the absence of tumor (mass) formation, leukemia is not diagnosed through imaging tests such as X-rays.
- Leukemia is most often a cancer of the white blood cells or WBCs. Some leukemia, however, may start in other types of blood cells.
- Leukemia is of many types. Some types of leukemia mostly affect adults while some are more common in children.
- Some leukemias are fast-growing (acute) while others are slow-growing or chronic leukemia.
- Leukemia may also be divided based upon their cells of origin as myeloid or lymphoid leukemia.
Treatment of leukemia varies according to the type of leukemia besides other factors such as the person’s age, stage of leukemia and presence of complications.
What causes leukemia?
Leukemia results when the genetic material (DNA) of a single cell in the bone marrow transforms, this is called a mutation. A mutated cell does not perform body function, but it eats away the nutrition meant for the normal cells. Every single mutated cell acts as the mother cells producing more abnormal cells.
The exact cause of the mutation is not well understood. Certain factors may put a person at risk of leukemia. These include:
- Previous cancer treatment: Previous treatment for cancer with radiation or chemotherapy may increase the risk of leukemia.
- Environmental chemicals: Exposure to certain chemicals such as benzene (used in several industries to make rubber, plastics, dyes, etc.) and formaldehyde (found in building materials and several household products like soaps and shampoos) can put a person at risk of leukemia.
- Cigarette smoking: Present or previous history of smoking increases the risk of several cancers including leukemia.
- Genetic disorders: Certain genetic disorders such as Down syndrome, neurofibromatosis, and Klinefelter syndrome may increase the risk of having leukemia
- Family history of leukemia: In most cases, there is no family history of leukemia, however, if a family member has been diagnosed with leukemia or a genetic disorder, it may increase your risk of leukemia.
What are the early signs and symptoms of leukemia?
The early signs and symptoms of leukemia are usually very subtle and non-specific.
Early symptoms are:
- Fever which keeps coming frequently
- Feeling tired and weak
- Looking pale
Other symptoms are:
- The tendency for bruising and bleeding: The person may complain of frequent nose and gum bleeds. There may be tiny reddish spots on the skin, called petechiae. Purplish patches or bruises may be seen on the skin.
- Pain and tenderness in bones or joints
- Swollen lymph nodes which may be felt in the neck, underarm, groin, or stomach
- An enlarged spleen or liver may be felt as heaviness or pain in the belly.
- Frequent infections.
- Unintended or unplanned weight loss.
- Night sweats.
- Pain or fullness felt under the ribs on the left side.
What are the complications of leukemia?
The complications of leukemia include:
- Frequent infections
- Tumor lysis syndrome (a condition caused by the rapid death of cancer cells during aggressive treatment)
- Organ damage such as liver and kidney failure
- Risk of other cancers
- Children receiving leukemia therapy may experience problems such as central nervous system (CNS) impairment, slowing of growth, infertility, cataract apart from an increased risk for other cancers.
Health Solutions From Our Sponsors
Top Leukemia: Signs, Symptoms, And Complications Related Articles
Arzerra (ofatumumab)Arzerra (ofatumumab) Injection is a monoclonal antibody used to treat chronic lymphocytic leukemia. Common side effects of Arzerra include nausea, vomiting, diarrhea, tiredness, swelling of hands/ankles/feet, trouble sleeping, skin rash, or cold symptoms such as stuffy nose, sneezing, and sore throat. Arzerra decreases bone marrow function, which can cause anemia.
Bendeka (bendamustine hydrochloride)Bendeka (bendamustine hydrochloride) Injection is an alkylating drug indicated for treatment of patients with chronic lymphocytic leukemia (CLL), and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. Common side effects of Bendeka include nausea, vomiting, fatigue, weakness, fever, diarrhea, constipation, anorexia, cough, headache, weight loss, shortness of breath, chills, pneumonia, drowsiness, rash, itching, inflammation of the mouth and lips, feeling unwell (malaise), dry mouth, and others.
Blincyto (blinatumomab)Blincyto (blinatumomab) for injection is a bispecific CD19-directed CD3 T- cell engager indicated for the treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Serious side effects of Blincyto include Cytokine Release Syndrome (CRS) and neurological toxicities.
Blood Cancer TypesTypes of blood cancers include leukemia, lymphomas, multiple myelomas, and others discussed in this slideshow. Symptoms may include fever, night sweats, fatigue, and other symptoms. Blood cancer treatment depends on the type of cancer and other factors. Blood tests for cancer as well as imaging tests and needle biopsy may help diagnose the condition.
Bosulif (bosutinib)Bosulif (bosutinib) is a prescription medicine used to treat adults who have a certain type of leukemia called Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) who are newly-diagnosed or who no longer benefit from or did not tolerate other treatment. Serious side effects of Bosulif include Stomach problems, low blood cell counts, liver problems, heart problems, fluid retention, and kidney problems.
Busulfex (busulfan)Busulfex (busulfan) is a cancer (antineoplastic) medication used to treat the symptoms of chronic myelogenous leukemia (a type of blood cancer). Busulfex is not a cure for leukemia. Common side effects of Busulfex include nausea, vomiting, diarrhea, constipation, loss of appetite, weight loss, mouth sores, upset stomach, abdominal pain, dizziness, weakness, swelling of the ankles/feet/hand, and others.
Guide to LeukemiaLearn about the common types and stages of leukemia, who gets it, symptoms, tests, treatments, and more. People with blood cancer are living longer than ever, and it may be curable.
Childhood Acute Lymphoblastic Leukemia (ALL)Childhood acute lymphoblastic leukemia is the most common type of cancer in children. Symptoms and signs include fever, easy bruising, bone or joint pain, weakness, loss of appetite, and painless lumps in the neck, underarm, stomach, or groin. Treatment depends upon staging and may include chemotherapy, radiation, or stem cell transplant.
How Does Leukemia Kill?Leukemia is a cancer of the white blood cells of the bone marrow. Patients with leukemia have an over-production of a particular blood cell type in the body, the white blood cells (cells that fight infection, and provide immunity).
Iclusig (ponatinib)Iclusig (ponatinib) is a prescription medicine used to treat adults who have chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) who cannot receive any other tyrosine kinase inhibitor (TKI) medicines. Serious side effects of Iclusig include arterial occlusion, venous thromboembolism, heart failure, and hepatoxicity (liver failure).
Inqovi (decitabine and cedazuridine)Inqovi (decitabine and cedazuridine) is a prescription medication used to treat adults with myelodysplastic syndromes (MDS), including chronic myelomonocytic leukemia (CMML). Serious side effects of Inqovi include low blood cell counts. It is not known if Inqovi is safe or effective in children.
LeukemiaLeukemia is a type of cancer of the blood cells in which the growth and development of the blood cells are abnormal. Strictly speaking, leukemia should refer only to cancer of the white blood cells (the leukocytes) but in practice it can apply to malignancy of any cellular element in the blood or bone marrow, as in red cell leukemia (erythroleukemia).
Leukemia QuizWhat do you know about leukemia? Did you know there are different types? What are the symptoms? Take the Leukemia Quiz and test your knowledge and get the facts.
What Is the Life Expectancy of a Person With Leukemia?Leukemia is a group of cancers of the blood affecting the white blood cells. White blood cells are the infection-fighting cells of the body.
In adults, leukemia is most common in people older than 55 years, with the average age of diagnosis being 66 years. It is also one of the most common cancers in children and adults younger than 20 years. The survival rate is higher for younger people.
Onureg (azacitidine)Onureg is a prescription medicine used for continued treatment of adults with acute myeloid leukemia (AML) who had a first complete remission (CR) following intensive induction chemotherapy with or without recovery of your blood cell counts, and who are not able to complete intensive curative therapy.
Tabloid (thioguanine)Tabloid (thioguanine 40-mg) is a cancer (antineoplastic) medication used to treat certain types of leukemia. Tabloid is sometimes given with other cancer medications. Tabloid may be available in generic form. Common side effects of Tabloid include upset stomach, nausea, vomiting, diarrhea, hair loss, itching or skin rash, or darkened skin color.
Valchlor (mechlorethamine)Valchlor is a prescription medicine used on the skin (topical) to treat people with Stage 1A and 1B mycosis fungoides-type cutaneous T-cell lymphoma, a type of blood cancer, who have received previous skin treatment. It is not known if Valchlor is safe and effective in children. Serious side effects include inflammation of your skin (dermatitis), and increased risk of certain types of skin cancers.
Venclexta (venetoclax)Venclexta is a prescription medicine used to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in combination with azacitidine, or decitabine, or low-dose cytarabine to treat adults with newly-diagnosed acute myeloid leukemia (AML) who are 75 years of age or older, or have other medical conditions that prevent the use of standard chemotherapy.